Barbieri CE - Search Results

1

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).

Marciscano AE, Wolfe S, Zhou XK, Barbieri CE, Formenti SC, Hu JC, Molina AM, Nanus DM, Nauseef JT, Scherr DS, Sternberg CN, Tagawa ST, Nagar H. Marciscano AE, et al. Among authors: barbieri ce. BMC Cancer. 2023 Aug 22;23(1):781. doi: 10.1186/s12885-023-11278-3. BMC Cancer. 2023. PMID: 37608258 Free PMC article. Clinical Trial.

2

Ureteroileal anastomosis with intraluminal visualization: technique and outcomes.

Barbieri CE, Schwartz MJ, Boorjian SA, Lee MM, Scherr DS. Barbieri CE, et al. Urology. 2010 Dec;76(6):1496-500. doi: 10.1016/j.urology.2010.01.035. Epub 2010 Apr 9. Urology. 2010. PMID: 20381836

3

Tissue-based molecular markers for bladder cancer.

Barbieri CE, Lotan Y, Lee RK, Sonpavde G, Karakiewicz PI, Robinson B, Scherr DS, Shariat SF. Barbieri CE, et al. Minerva Urol Nefrol. 2010 Sep;62(3):241-58. Minerva Urol Nefrol. 2010. PMID: 20940694 Review.

4

Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.

Barbieri CE, Cha EK, Chromecki TF, Dunning A, Lotan Y, Svatek RS, Scherr DS, Karakiewicz PI, Sun M, Mazumdar M, Shariat SF. Barbieri CE, et al. BJU Int. 2012 Mar;109(5):685-90. doi: 10.1111/j.1464-410X.2011.010419.x. Epub 2011 Aug 18. BJU Int. 2012. PMID: 21851550

5

Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.

Shariat SF, Chromecki TF, Hoefer J, Barbieri CE, Scherr DS, Karakiewicz PI, Roehrborn CG, Montorsi F, Culig Z, Cavarretta IT. Shariat SF, et al. Among authors: barbieri ce. J Urol. 2011 Nov;186(5):2107-14. doi: 10.1016/j.juro.2011.06.048. Epub 2011 Sep 23. J Urol. 2011. PMID: 21944124

6

Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.

Shoag J, Halpern JA, Lee DJ, Mittal S, Ballman KV, Barbieri CE, Hu JC. Shoag J, et al. Among authors: barbieri ce. J Urol. 2016 Oct;196(4):1047-52. doi: 10.1016/j.juro.2016.03.171. Epub 2016 Apr 6. J Urol. 2016. PMID: 27060052

7

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

Shoag J, Mittal S, Halpern JA, Scherr D, Hu JC, Barbieri CE. Shoag J, et al. Among authors: barbieri ce. Eur Urol. 2016 Jul;70(1):2-5. doi: 10.1016/j.eururo.2016.01.009. Epub 2016 May 7. Eur Urol. 2016. PMID: 27166670 Free PMC article. Clinical Trial.

8

Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial.

Lewicki P, Shoag J, Golombos DM, Oromendia C, Ballman KV, Halpern JA, Stone BV, O'Malley P, Barbieri CE, Scherr DS. Lewicki P, et al. Among authors: barbieri ce. J Urol. 2017 Apr;197(4):1014-1019. doi: 10.1016/j.juro.2016.11.002. Epub 2016 Nov 8. J Urol. 2017. PMID: 27836710

9

Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.

O'Malley PG, Nguyen DP, Al Hussein Al Awamlh B, Wu G, Thompson IM, Sanda M, Rubin M, Wei JT, Lee R, Christos P, Barbieri C, Scherr DS. O'Malley PG, et al. J Urol. 2017 Jul;198(1):42-49. doi: 10.1016/j.juro.2017.01.058. Epub 2017 Jan 20. J Urol. 2017. PMID: 28115190 Free PMC article.

10

Molecular alterations in prostate cancer and association with MRI features.

Lee D, Fontugne J, Gumpeni N, Park K, MacDonald TY, Robinson BD, Sboner A, Rubin MA, Mosquera JM, Barbieri CE. Lee D, et al. Among authors: barbieri ce. Prostate Cancer Prostatic Dis. 2017 Dec;20(4):430-435. doi: 10.1038/pcan.2017.33. Epub 2017 Aug 1. Prostate Cancer Prostatic Dis. 2017. PMID: 28762374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page